Qualigen and its strategic partners will be conducting clinical studies that explore the use of therapeutic product candidates developed by Qualigen in different cancer settings. Approval by regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), is required to make our medicines available to patients. Therefore, our priority is to enroll patients in clinical trials in order to obtain the data required for review and approval by regulatory authorities.

Cancer Resources

To learn about cancer and available treatments, please visit the following: